Asian Venture Capital Journal (AVCJ)
Chinese PE firm Yunfeng Capital and Hong Kong-listed medical device manufacturer MicroPort Scientific Corporation will acquire US-listed LivaNova's cardiac rhythm management (CRM) business for $190 million in cash.
Baird Capital has acquired a minority stake in Nirvana Asia, a funeral services business that was privatized by CVC Capital Partners in 2016 in conjunction with the company’s founder.
Emerging markets private capital fundraising – led by emerging Asia – reached its highest point since the before the global financial crisis in 2017, according to EMPEA, with capital dispersed more evenly across different strategies than ever before.
Demographic shifts are prompting Australian GPs to reevaluate domestic consumer plays with an eye toward processes rather than goods. Overseas markets are an increasingly important part of the equation
Tim Sims, co-founder and managing director of Pacific Equity Partners, discusses competition in Australian private equity, approaches to co-investment, succession planning, and his firm’s secured assets fund
Jesper Koll, head of Japan for WisdomTree Asset Management, summons 30 years of Japanese investment experience to predict a durable growth story where an aging population has its advantages
Ardian has opened an office in Tokyo - its third in Asia - with a view to capitalizing on growing demand for exposure to alternatives, including private equity, from Japanese institutional investors.
Kevin Zhang, one of the two co-founders of Chinese middle market private equity firm Ascendent Capital Partners, is retiring from the firm. He is understood to be planning to establish his own family office.